Mobile

A study to compare the effect of inhaled treatments: the combination of 3 components (beclometasone/formoterol/glycopyrrolate) to a known single treatment (tiotropium) or the double combination of tio...

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-000063-91

A study to compare the effect of inhaled treatments: the combination of 3 components (beclometasone/formoterol/glycopyrrolate) to a known single treatment (tiotropium) or the double combination of tiotropium (Spiriva) and beclometasone plus formoterol in patients with chronic obstructive pulmonary disease treated for one year

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate the superiority of CHF 5993 pMDI over Tiotropium in terms of moderate and severe COPD exacerbation rate over 52 weeks of treatment.

Critère d'inclusion

  • Chronic Obstructive Pulmonary Disease (COPD)

Liens